{"data":{"id":"us/21-cfr-522.500","jurisdiction":"us","citation":"21 CFR 522.500","heading":"Cosyntropin injection.","body":"(a) Sponsor. See No. 043264 in § 510.600(c) of this chapter.\n(b) Specifications. Each milliliter (mL) contains 0.25 milligrams (mg) cosyntropin, 1 mg glacial acetic acid, 0.82 mg sodium acetate trihydrate, 8.1 mg sodium chloride, and water for injection (to 100%).\n(c) Conditions of use—(1) Amount. Administer 0.25 mg (1 mL) per dog weighing 10-110 pounds (4.5-50 kilograms) by intravenous or intramuscular injection.\n(2) Indications for use. For the evaluation of adrenal function in dogs.\n(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. It is a violation of Federal law to use this product other than as directed in the labeling.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER E—ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS","PART 522—IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"5eb485c40ca1641b3df7bdaa6e8ca89e1ffda952a14ea957504ea46ac45e8e0e","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-522.480","next":"us/21-cfr-522.522"},"notice":"GroundRules: Original legal text. Not legal advice."}